Blog posts

5 ways our researchers are working to better spot and treat cancer

Cancer survival is improving and today, half of people diagnosed will survive their disease. This is thanks to research. Research that’s guiding governments to change their policies, underpinning awareness campaigns and educational initiatives, turning discoveries into treatments and prevention measures.

But there’s still much to be done to help more people survive, by catching the disease earlier and developing better treatments.

This World Cancer Day, and as part of our celebrations to mark IGHI’s 10th anniversary this year, find out how our researchers are working to make that happen. Join us in exploring some of our projects that could lead to better detection, diagnosis and treatment of cancer.

How we’re using data to improve healthcare

‘Big Data’ has become a bit of a buzzword. But for us at the Big Data and Analytical Unit, it’s our bread and butter.

The Big Data and Analytical Unit (BDAU) is the health data hub in IGHI’s Centre for Health Policy. We’re a multidisciplinary team that collaborates with clinicians, academics and data scientists across the College (and beyond!) to support improvements in health through better use of data. But what exactly does that mean?

Here’s a typical day for the BDAU to show you what that looks like in practice.

Feedback First – making patient complaints easier to digest

People complain for a variety of reasons. But international evidence consistently finds that most people complain to prevent incidents from happening to others – they want to see change as a result, when they feel something isn’t right. Making a complaint can therefore be an empowering process, if people know – or feel – that their actions could make a difference.

Dealing with complaints is an important learning process for those that the complaint is directed against, but also the institution more widely. They can highlight problems that may have otherwise slipped through the net, prompting action that can prevent the same mistakes happening again and affecting more people.

A simple piece of paper to help make taking medicines safer

Taking medicines is the most common way that we attempt to stave off or treat illness. Every day people all across the world use medicines to help improve their health and wellbeing. They’ve transformed the treatment and outlook for many diseases, helping people live longer and healthier lives. Yet medicines are also a major risk to patients’ safety. And this risk is not only a result of drugs’ side effects.

Mistakes in the treatment process can also lead to patient harm. Errors can happen at any stage of the pathway; when professionals prescribe, dispense and administer drugs. In England alone, it’s estimated that over 230 million such errors occur every year, causing hundreds of deaths and contributing to thousands more.

What’s it like to… be a designer in healthcare?

By Pip Batey, Design Strategist, Helix Centre, IGHI

I have always cared about social causes, particularly within mental health and environmental-related issues. I enjoy making sense of complex problems and taking concrete steps to improve systems that can have a lasting positive impact. Both of these elements are a core part of Helix’s ethos and ways of working. 

Words of advice to student innovators, by Dr Richard Smith

This week we’re opening applications for IGHI’s annual Student Challenges Competition. We’re inviting aspiring global health innovators to submit their project in a bid to win £10,000.

To help budding student innovators get started, IGHI Visiting Professor and former BMJ editor Dr Richard Smith reveals his most essential pieces of advice.

NHS data is valuable – how can it ensure a fair return?

By Gianluca Fontana and Saira Ghafur, Centre for Health Policy

Our National Health Service owns some of the most comprehensive patient data sets across the globe. This makes these data a very valuable asset – not just as a springboard for improving health and care through learning from the data, but also in terms of the potential for financial return. It is critical that if the NHS shares this data with companies, in an appropriate and secure way, it also receives a fair share of this financial return.

These are arguments we make in a new article published in Lancet Digital Health.